MAPLIGHT THERAPEUTICS INCMPLT
ASignal's systematic analysis rates MPLT as Bearish.
Reflects the latest available analysis · analyzed Sep 27, 2026
The case on MPLT
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Extremely oversold RSI (9.83) suggests potential for mean reversion
- Strong cash position with $304.72M total cash and minimal debt (debt/equity 0.01x)
- High liquidity ratios (current ratio 16.52x, quick ratio 15.79x) indicate low near-term solvency risk
- Negative MACD (-1.26) below signal line with declining histogram, indicating bearish momentum
- Price significantly below SMA20 and SMA50, with strong downtrend confirmed by negative price momentum (-0.20)
- Negative return on equity (-111.55%) and return on assets (-67.11%) reflect severe profitability deterioration
- Negative operating and free cash flow ($-174.67M and $-95.21M respectively) signal ongoing financial burn
- Extremely weak margins (0.00% across gross, operating, and net) indicate lack of revenue monetization
See the full verdict on MPLT
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MPLT
Most investors never get a second opinion, let alone several. ASignal runs MPLT past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.